EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Repeated dexamethasone suppression test during depressive illness normalization of test results compared with clinical improvement



Repeated dexamethasone suppression test during depressive illness normalization of test results compared with clinical improvement



Journal of Affective Disorders 4(2): 93-102



Serial plasma cortisol concentrations were recorded under controlled conditions after an overnight dexamethasone suppression (DST) in 20 depressed patients with initially abnormal test results. The cortisol levels were related to clinical course., All 20 patients showed normalization of hypothalamic-pituitary-adrenal (HPA) hyperactivity, a mean of 3.4 .+-. 1.8 wk before clinical recovery was achieved. In 4 clinically remitted patients the endocrine disturbance as evidenced by abnormal DST results preceded a depressive relapse. DST results did not appear to be affected by psychotropic drugs including benzodiazepines.

(PDF 0-2 workdays service: $29.90)

Accession: 006312906

Download citation: RISBibTeXText

PMID: 6213695



Related references

Normalization of the dexamethasone suppression test a correlate of clinical improvement in primary depressives. British Journal of Psychiatry 147(JULY): 30-35, 1985

The clinical diagnostic value of dexamethasone suppression test in depressive illness. Annals of the Academy of Medicine, Singapore 14(1): 104-109, 1985

The dexamethasone suppression test in depressive illness clinical correlates. Psychoneuroendocrinology 7(4): 295-302, 1982

Clinical application of the dexamethasone suppression test in major depressive illness. Journal of the Kentucky Medical Association 81(9): 697-699, 1983

The specificity of the thyrotropin-releasing hormone (TRH) test and dexamethasone suppression test (DST) for major depressive illness in alcoholics. Nida Research Monograph 43: 266-272, 1983

Hypothesis of a deficiency of central noradrenergic input in dexamethasone suppression test nonsuppressor depressed patients a clinical study with determination of dexamethasone suppression test and plasma 3 4 dihydroxphenylethyleneglycol negative results. Kemali, D And G Racagni (Ed ) Advances in Biochemical Psychopharmacology, Vol 40 Chronic Treatments in Neuropsychiatry Xvii+219p Raven Press: New York, N Y , Usa Illus 99-102, 1985

Serial dexamethasone suppression test in manic depressive illness depressive state and related psychoses a 29 cases study. Encephale 11(4): 171-174, 1985

Dexamethasone suppression test in diagnosis of depressive illness. Clinical Pharmacy 2(6): 538-545, 1983

Performance of the dexamethasone suppression test in depressive illness according to ICD and DSM-III classification systems. British Journal of Psychiatry 152: 554-558, 1988

Dexamethasone suppression test in depressive illness: its relation to anxiety symptoms. British Journal of Psychiatry 144: 181-184, 1984

The prognosis of primary depressive illness. Its relationship to the dexamethasone suppression test. British Journal of Psychiatry 150: 787-790, 1987

The use of the dexamethasone suppression test as a biological indicator of depressive illness in patients with epilepsy. Acta Neurologica Scandinavica 70(3): 233, 1984

Research protocol on the usage of the dexamethasone suppression test (DST) as a biological indicator of depressive illness. Progress in Neuro-Psychopharmacology and Biological Psychiatry 8(1): 187-189, 1984

Research protocol on the usage of the Dexamethasone Suppression Test (DST) as a biological indicator of depressive illness. WHO collaborative study. Progress in Neuro-Psychopharmacology & Biological Psychiatry 8(1): 187-189, 1984

The predictive power of the salivary cortisol dexamethasone suppression test for three-year outcome in major depressive illness. Journal of Psychiatric Research 23(2): 151-156, 1989